These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2778374)

  • 1. [Effect of remission induction chemotherapy on blood coagulability in patients with gynecological malignancies].
    Sawaguchi K; Yabushita H; Higuchi K; Noguchi M; Ishihara M; Aoyama T; Menjoh H; Oguri T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):798-808. PubMed ID: 2778374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
    Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
    Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
    Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].
    Gando S; Tedo I
    Rinsho Ketsueki; 1990 Nov; 31(11):1774-9. PubMed ID: 2149574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on dynamic changes in coagulability and von Willebrand factor and its correlation with prognosis of cardiopulmonary resuscitation].
    Zhou JX; Qi LM; Cheng RN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec; 21(12):734-7. PubMed ID: 20042140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in coagulability and fibrinolytic activity in the patients with ovarian hyperstimulation syndrome].
    Manaka C; Akabori A; Araki S; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1653-9. PubMed ID: 1744464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
    Oberhoff C; Hoffmann O; Winkler UH; Schindler AE
    Gynecol Endocrinol; 2001 Oct; 15(5):341-8. PubMed ID: 11727356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
    Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
    Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part II. Influence of treatment on time of remission and patients survival].
    Ochmański W
    Przegl Lek; 2008; 65(7-8):321-8. PubMed ID: 19004228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.